Premium
CAVEAT mTOR: You’ve heard about the benefits of using mTOR inhibitors, here are some of the risks
Author(s) -
Eisen Howard J.
Publication year - 2021
Publication title -
american journal of transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.89
H-Index - 188
eISSN - 1600-6143
pISSN - 1600-6135
DOI - 10.1111/ajt.16225
Subject(s) - medicine , pi3k/akt/mtor pathway , discovery and development of mtor inhibitors , intensive care medicine , genetics , signal transduction , biology
Eisen reviews Asleh et al.'s article ( page 626) that shows that the development of significant proteinuria after conversion to mTOR‐ based immunosuppression is a harbinger of poor outcomes for cardiac transplant recipients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom